Therapeutic translation in acute kidney injury: The epithelial/endothelial axis

Research output: Contribution to journalArticle

90 Citations (Scopus)

Abstract

Acute kidney injury (AKI) remains a major clinical event with rising incidence, severity, and cost; it now has a morbidity and mortality exceeding acute myocardial infarction. There is also a documented conversion to and acceleration of chronic kidney disease to end-stage renal disease. The multifactorial nature of AKI etiologies and pathophysiology and the lack of diagnostic techniques have hindered translation of preclinical success. An evolving understanding of epithelial, endothelial, and inflammatory cell interactions and individualization of care will result in the eventual development of effective therapeutic strategies. This review focuses on epithelial and endothelial injury mediators, interactions, and targets for therapy.

Original languageEnglish
Pages (from-to)2355-2363
Number of pages9
JournalJournal of Clinical Investigation
Volume124
Issue number6
DOIs
StatePublished - Jun 2 2014

Fingerprint

Acute Kidney Injury
Chronic Renal Insufficiency
Cell Communication
Chronic Kidney Failure
Endothelial Cells
Myocardial Infarction
Morbidity
Costs and Cost Analysis
Mortality
Incidence
Wounds and Injuries
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Therapeutic translation in acute kidney injury : The epithelial/endothelial axis. / Molitoris, Bruce.

In: Journal of Clinical Investigation, Vol. 124, No. 6, 02.06.2014, p. 2355-2363.

Research output: Contribution to journalArticle

@article{e940152646ef4fb18b4948eec551961c,
title = "Therapeutic translation in acute kidney injury: The epithelial/endothelial axis",
abstract = "Acute kidney injury (AKI) remains a major clinical event with rising incidence, severity, and cost; it now has a morbidity and mortality exceeding acute myocardial infarction. There is also a documented conversion to and acceleration of chronic kidney disease to end-stage renal disease. The multifactorial nature of AKI etiologies and pathophysiology and the lack of diagnostic techniques have hindered translation of preclinical success. An evolving understanding of epithelial, endothelial, and inflammatory cell interactions and individualization of care will result in the eventual development of effective therapeutic strategies. This review focuses on epithelial and endothelial injury mediators, interactions, and targets for therapy.",
author = "Bruce Molitoris",
year = "2014",
month = "6",
day = "2",
doi = "10.1172/JCI72269",
language = "English",
volume = "124",
pages = "2355--2363",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "6",

}

TY - JOUR

T1 - Therapeutic translation in acute kidney injury

T2 - The epithelial/endothelial axis

AU - Molitoris, Bruce

PY - 2014/6/2

Y1 - 2014/6/2

N2 - Acute kidney injury (AKI) remains a major clinical event with rising incidence, severity, and cost; it now has a morbidity and mortality exceeding acute myocardial infarction. There is also a documented conversion to and acceleration of chronic kidney disease to end-stage renal disease. The multifactorial nature of AKI etiologies and pathophysiology and the lack of diagnostic techniques have hindered translation of preclinical success. An evolving understanding of epithelial, endothelial, and inflammatory cell interactions and individualization of care will result in the eventual development of effective therapeutic strategies. This review focuses on epithelial and endothelial injury mediators, interactions, and targets for therapy.

AB - Acute kidney injury (AKI) remains a major clinical event with rising incidence, severity, and cost; it now has a morbidity and mortality exceeding acute myocardial infarction. There is also a documented conversion to and acceleration of chronic kidney disease to end-stage renal disease. The multifactorial nature of AKI etiologies and pathophysiology and the lack of diagnostic techniques have hindered translation of preclinical success. An evolving understanding of epithelial, endothelial, and inflammatory cell interactions and individualization of care will result in the eventual development of effective therapeutic strategies. This review focuses on epithelial and endothelial injury mediators, interactions, and targets for therapy.

UR - http://www.scopus.com/inward/record.url?scp=84902136264&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902136264&partnerID=8YFLogxK

U2 - 10.1172/JCI72269

DO - 10.1172/JCI72269

M3 - Article

C2 - 24892710

AN - SCOPUS:84902136264

VL - 124

SP - 2355

EP - 2363

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 6

ER -